HIDRADENITIS SUPPURATIVA (HS)
Clinical trials for HIDRADENITIS SUPPURATIVA (HS) explained in plain language.
Never miss a new study
Get alerted when new HIDRADENITIS SUPPURATIVA (HS) trials appear
Sign up with your email to follow new studies for HIDRADENITIS SUPPURATIVA (HS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for HS sufferers: Long-Term drug safety trial underway
Disease control OngoingThis study tests the long-term safety and effectiveness of the drug povorcitinib in people with moderate to severe hidradenitis suppurativa (HS), a painful skin condition. Participants have already completed a previous 54-week study of the same drug. The goal is to see if povorci…
Matched conditions: HIDRADENITIS SUPPURATIVA (HS)
Phase: PHASE3 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated May 12, 2026 13:41 UTC
-
Botox study for painful skin condition pulled before start
Symptom relief TerminatedThis study aimed to see if Botulinum Toxin-A (Botox) could help people with hidradenitis suppurativa, a painful skin condition. It planned to enroll adults with active armpit lesions and measure changes in lesion count and quality of life. However, the study was withdrawn before …
Matched conditions: HIDRADENITIS SUPPURATIVA (HS)
Phase: PHASE4 • Sponsor: Yale University • Aim: Symptom relief
Last updated May 07, 2026 18:42 UTC